BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Charpiat B, Bleyzac N, Tod M. Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19? Clin Drug Investig. 2020;40:897-899. [PMID: 32779119 DOI: 10.1007/s40261-020-00963-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Homolak J, Kodvanj I, Trkulja V. An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clin Drug Investig 2021;41:287-9. [PMID: 33606199 DOI: 10.1007/s40261-021-01007-8] [Reference Citation Analysis]
2 Etemad-Moghadam S, Alaeddini M. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature. Int J Dent 2021;2021:6648082. [PMID: 34054961 DOI: 10.1155/2021/6648082] [Reference Citation Analysis]
3 Park J, You SC, Cho J, Park CH, Shin WG, Park RW, In Seo S. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study. BMC Pharmacol Toxicol 2022;23:9. [PMID: 35039078 DOI: 10.1186/s40360-022-00549-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ong JS, Gharahkhani P, Vaughan TL, Whiteman D, Kendall BJ, MacGregor S. Assessing the genetic relationship between gastro-esophageal reflux disease and risk of COVID-19 infection. Hum Mol Genet 2021:ddab253. [PMID: 34553760 DOI: 10.1093/hmg/ddab253] [Reference Citation Analysis]
5 da Rosa TF, Foletto VS, Serafin MB, Bottega A, Hörner R. Anti-infective properties of proton pump inhibitors: perspectives. Int Microbiol 2021. [PMID: 34476634 DOI: 10.1007/s10123-021-00203-y] [Reference Citation Analysis]
6 Chaudhuri N, George PM, Kreuter M, Molina-Molina M, Rivera-Ortega P, Stella GM, Stewart I, Spencer LG, Wells AU, Jenkins RG. Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology? Am J Respir Crit Care Med 2021;203:522-4. [PMID: 33217244 DOI: 10.1164/rccm.202011-4146LE] [Reference Citation Analysis]
7 Quade BN, Parker MD, Occhipinti R. The therapeutic importance of acid-base balance. Biochem Pharmacol 2021;183:114278. [PMID: 33039418 DOI: 10.1016/j.bcp.2020.114278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Veremme L, Janoly-Dumenil A, Charpiat B. Curbing proton pump inhibitor overprescribing: Multifaceted strategies in an academic hospital. J Clin Pharm Ther 2021;46:1041-5. [PMID: 33629438 DOI: 10.1111/jcpt.13395] [Reference Citation Analysis]
9 Pranata R, Huang I, Lawrensia S, Henrina J, Lim MA, Lukito AA, Kuswardhani RAT, Wibawa IDN. Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis. Pharmacol Rep 2021;73:1642-9. [PMID: 33840053 DOI: 10.1007/s43440-021-00263-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zippi M, Fiorino S, Budriesi R, Micucci M, Corazza I, Pica R, de Biase D, Gallo CG, Hong W. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis. World J Clin Cases 2021; 9(12): 2763-2777 [PMID: 33969059 DOI: 10.12998/wjcc.v9.i12.2763] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg 2021:trab042. [PMID: 33728439 DOI: 10.1093/trstmh/trab042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Roulet L. A nationwide cohort study with propensity score matching. Gut 2021;70:1802-3. [PMID: 33077573 DOI: 10.1136/gutjnl-2020-323098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Fatima K, Almas T, Lakhani S, Jahangir A, Ahmed A, Siddiqui A, Rahim A, Qureshi SA, Arshad Z, Golani S, Musheer A. The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis. TropicalMed 2022;7:37. [DOI: 10.3390/tropicalmed7030037] [Reference Citation Analysis]
14 Lv XH, Wang ZJ, Yang JL. Proton Pump Inhibitors and COVID-19: Confusing Status Quo. Am J Gastroenterol 2021;116:2153. [PMID: 34397446 DOI: 10.14309/ajg.0000000000001407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]